Core Viewpoint - Citigroup has raised the target price for Kintor Pharmaceutical (00148) from HKD 45 to HKD 48, maintaining a "Buy" rating, indicating positive sentiment towards the company's future performance [1] Financial Performance - Kintor's revenue for 2025 is projected to grow by 5% to HKD 45.375 billion, aligning with market expectations [1] - Net profit is expected to surge by 170% to HKD 4.402 billion, exceeding previous guidance of over HKD 4.32 billion, primarily due to higher-than-expected investment income of HKD 2.635 billion [1] - Adjusted core net profit, excluding revaluation losses and investment income, is forecasted to decline by 4% year-on-year to HKD 2.635 billion [1] Earnings Forecast Adjustments - Due to a recent placement of Kintor's shares (01888), which will reduce profit contributions, the 2026 core earnings forecast has been cut by 11% [1] - Anticipated contributions from several upcoming AI upstream materials and chemical projects are expected to boost the 2027 earnings forecast by 4% [1] - A new earnings forecast for 2028 has been introduced, projecting a compound annual growth rate of 24% for core earnings, reaching HKD 5.029 billion by 2028 [1] Comparative Analysis - Based on the pure AI upstream materials layout, Citigroup believes that Kintor's layered board is superior to Kintor Group, with expectations for further revaluation of its valuation [1]

Core Viewpoint - The stock prices of Kwan Tong Group and Kwan Tong Laminated Board have declined following the announcement of a share placement, which is expected to dilute the group's ownership in the subsidiary [1] Group 1: Stock Performance - Kwan Tong Group's stock fell by 5.1%, trading at HKD 37.56 [1] - Kwan Tong Laminated Board's stock decreased by 3.63%, trading at HKD 21.22 [1] Group 2: Share Placement Details - Kwan Tong Group plans to place up to 130 million shares of Kwan Tong Laminated Board at a discount of approximately 8.7%, representing about 4.15% of the total issued share capital [1] - Post-transaction, Kwan Tong Group's ownership in Kwan Tong Laminated Board will decrease from 71.10% to 66.95%, while Kwan Tong Laminated Board remains a subsidiary [1] Group 3: Company Strategy - The company believes that the share placement will enhance the liquidity of the shares in the market, broaden the shareholder base, and promote more active trading, thereby improving the overall market image of the company [1]

Core Viewpoint - Citigroup's report indicates that Kwan Tong Group's revenue is expected to grow by 5% to HKD 45.375 billion in 2025, aligning with market expectations, while net profit is projected to increase by 170% to HKD 4.402 billion, primarily due to higher-than-expected investment income of HKD 2.635 billion [1] Revenue and Profit Forecast - The adjusted core net profit, excluding revaluation losses and investment income, is expected to decline by 4% year-on-year to HKD 2.635 billion [1] - Following a recent placement of 4% of Kwan Tong's shares, which will reduce profit contributions, the 2026 core profit forecast has been revised down by 11% [1] Future Earnings Projections - Anticipated contributions from several upcoming AI upstream materials and chemical projects are expected to generate initial year revenues, leading to a 4% increase in the 2027 profit forecast [1] - A new profit forecast for 2028 has been introduced, with a projected compound annual growth rate of 24% for core earnings, reaching HKD 5.029 billion [1] Target Price and Rating - The target price for Kwan Tong Group has been raised from HKD 45 to HKD 48, maintaining a "Buy" rating [1] - Based on the pure AI upstream materials layout, Kwan Tong Laminates is still considered superior to Kwan Tong Group, with expectations for further valuation reassessment [1]

Core Viewpoint - The stock of Kintor Pharmaceutical (01888) opened nearly 7% lower, reflecting market reaction to Kintor Group's announcement of a share placement at a discount, which is expected to dilute existing shareholders' stakes [1] Group 1: Share Placement Details - Kintor Group plans to place up to 130 million shares of Kintor Pharmaceutical, representing 4.15% of its issued share capital [1] - The placement price is set at HKD 21 per share, which is an 8.7% discount compared to the closing price of HKD 23 on March 17 [1] - The estimated net proceeds from the placement are approximately HKD 2.72 billion, intended for general working capital [1] Group 2: Shareholding Changes - Following the completion of the placement, Kintor Group's shareholding in Kintor Pharmaceutical will decrease from 71.1% to 66.95% [1] - Kintor Group has committed not to sell any further shares for 90 days following the completion of the placement [1] Group 3: Market Impact - The stock price of Kintor Pharmaceutical fell by 6.96% to HKD 21.4, with a trading volume of HKD 2.784 billion at the time of reporting [1] - The company believes that the placement will enhance the liquidity of its shares in the market and broaden its shareholder base [1]

Core Viewpoint - 建滔积层板's stock price dropped nearly 7% following the announcement of a share placement by its parent company, 建滔集团, which aims to raise approximately 2.72 billion HKD for general operational funds [1] Group 1: Share Placement Details - 建滔集团 plans to place up to 130 million shares of 建滔积层板, representing 4.15% of its issued share capital [1] - The placement price is set at 21 HKD per share, which is an 8.7% discount compared to the closing price of 23 HKD on March 17 [1] - The net proceeds from the placement are estimated to be around 2.72 billion HKD [1] Group 2: Ownership and Market Impact - Following the completion of the placement, 建滔集团's ownership in 建滔积层板 will decrease from 71.1% to 66.95% [1] - The company believes that the placement will enhance the liquidity of its shares in the market and broaden its shareholder base [1]

Core Viewpoint - Kwan Tong Group (00148) has announced a placement agreement to sell up to 130 million shares, representing approximately 4.15% of its issued share capital, at a price of HKD 21.00 per share, which is an 8.7% discount to the closing price of HKD 23.00 on March 17, 2026 [1]. Group 1 - The sale is expected to reduce the company's direct and indirect ownership in Kwan Tong Group's issued share capital from approximately 71.10% to about 66.95% after the completion of the sale [1]. - Despite the reduction in ownership, Kwan Tong Group will remain a subsidiary of the company, and its financial performance will continue to be consolidated into the company's financial statements [1]. - The estimated net proceeds from the sale, after deducting related transaction costs and expenses, are approximately HKD 2.72 billion, which will be used for the company's general working capital [1]. Group 2 - The transaction is anticipated to enhance the company's overall liquidity position, providing additional financial resources to support ongoing operations and future development [1].

Core Viewpoint - The company, Kwan Tong Group, has announced a placement agreement to sell up to 130 million shares, representing approximately 4.15% of its issued share capital, at a price of HKD 21.00 per share, which is an 8.7% discount to the closing price on March 17, 2026 [1] Group 1 - The placement is expected to generate a net proceeds of approximately HKD 2.72 billion after deducting related transaction costs and expenses [1] - The proceeds will be used for general working capital purposes, enhancing the company's overall liquidity position and providing additional financial resources for ongoing operations and future development [1] - Following the completion of the sale, the company's direct and indirect ownership in Kwan Tong Group's issued share capital will decrease from approximately 71.10% to about 66.95%, maintaining its status as a subsidiary [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 KINGBOARD HOLDINGS LIMITED 建滔集團有限公司 （於 開 曼 群 島 註 冊 成 立 之 有 限 公 司） （股 份 代 號：148） 須予披露的交易 透過配售方式出售建滔積層板之股份 緒 言 於二零二六年三月十八日（交 易 時 段 前），本 公 司 與 配 售 代 理 訂 立 大 宗 交 易 協 議，據 此，本 公 司 已 同 意 透 過 配 售 代 理 按 出 售 價 向 配 售 代 理 將 按 盡 力 基 準 促 使 之承配人出售最多130,000,000股 銷 售 股 份，佔 建 滔 積 層 板 於 本 公 告 日 期 已 發 行 股本總額約4.15%。 大宗交易協議 大 宗 交 易 協 議 之 主 要 條 款 載 列 如 下： 日 期： 二零二六年三月十八日 訂 約 方： (1) 本公司（作 為 賣 方）；及 (2 ...

Group 1: Market Overview - The Hang Seng Index experienced a rebound, closing up 368 points or 1.45%, indicating a potential recovery from recent geopolitical pressures [2][3] - The technology sector outperformed the market, with notable gains from major companies such as Tencent (+2%), Alibaba (+1.1%), and Meituan (+3.1%) [3] Group 2: Macro & Industry Dynamics - UBS predicts that the MSCI China Index is expected to outperform global markets by 5% this year, with a target of reaching 100 points by year-end, representing a potential increase of approximately 20% from current levels [6] - The Chinese economy's lower reliance on imported oil and the resilience of Chinese assets are highlighted as factors contributing to this positive outlook [6] - In February, the housing prices in 70 major cities in China fell by 3.2% year-on-year, marking the largest decline in eight months, although the monthly decline narrowed to 0.3% [7] Group 3: Company News - FWD Group reported record profits last year and expressed confidence in maintaining growth momentum, with plans to invest in business and talent [9] - Kwan Tai Group announced a significant increase in net profit by 1.7 times, with a total profit of 4.402 billion HKD for the year ending December 2025 [10] - Q Technology reported a net profit of 1.494 billion RMB, a year-on-year increase of 4.35 times, driven by a nearly 30% increase in revenue [12]

Core Viewpoint - 建滔集团 reported strong financial results for the year ending December 31, 2025, with significant increases in revenue and profit, driven by robust demand in the electronics market, particularly in AI-related products [1] Financial Performance - The company achieved a revenue of 45.375 billion HKD, representing a year-on-year increase of 5% [1] - Profit attributable to shareholders was 4.402 billion HKD, a substantial increase of 169.98% compared to the previous year [1] - Basic earnings per share were reported at 3.971 HKD [1] - The company proposed a final dividend of 1.11 HKD per share and a special final dividend of 0.40 HKD per share [1] Market Demand and Product Performance - The overall demand in the electronics market remained strong, with rapid development in high-end sectors such as artificial intelligence (AI) [1] - There was a robust demand for emerging electronic products related to AI, including copper-clad laminates and upstream materials like AI electronic glass fiber yarn, AI electronic glass fiber cloth, and copper foil [1] - The prices of copper-clad laminates and related upstream materials saw significant increases, along with growth in sales compared to the same period in 2024, contributing to higher profits in the copper-clad laminate segment [1] - The business environment for the copper-clad laminate industry chain continued to improve [1]